Takeda Pharmaceuticals Korea Co., Ltd.
The China Biomarker Lead provides scientific and operational leadership for Translational Medicine and biomarker studies in China, collaborating with key opinion leaders and cross-functional teams. This role involves overseeing the end-to-end planning, validation, and execution of biomarker assays at China-based CROs to support clinical trials and global development programs. The position requires strategic relationship building, regulatory compliance, and the implementation of innovative biomarker technologies to advance Takeda's translational capabilities in the region.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Takeda Pharmaceuticals Korea Co., Ltd..
Takeda Pharmaceuticals Korea Co., Ltd. didn’t post a salary, so this is our estimate from similar listings.
China Biomarker Lead
BioLife Plasma Services
Associate Director, Clinical Biomarker
lifelancer
Associate Director, Global Biomarker Lead, Inflammation, GI2 TAU
BioLife Plasma Services
Senior Director, Biomarker Development, Strategy, and Operations
Zenas BioPharma
Senior Scientist
Merck & Co., Inc.
Translational Medicine China Team
AstraZeneca